Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Non Operating Income (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Non Operating Income for 3 consecutive years, with -$8.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 56.94% to -$8.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 2165.14% increase, with the full-year FY2025 number at $2.3 million, up 2165.14% from a year prior.
  • Non Operating Income was -$8.7 million for Q4 2025 at Nuvation Bio, down from $642000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.9 million in Q2 2024 to a low of -$20.3 million in Q4 2024.
  • A 3-year average of $2.2 million and a median of $5.4 million in 2023 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: plummeted 388.19% in 2024, then skyrocketed 56.94% in 2025.
  • Nuvation Bio's Non Operating Income stood at $7.0 million in 2023, then tumbled by 388.19% to -$20.3 million in 2024, then surged by 56.94% to -$8.7 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Non Operating Income are -$8.7 million (Q4 2025), $642000.0 (Q3 2025), and $4.6 million (Q2 2025).